The relationships between CSF tau measures and other biomarkers probably reflect the timing of biomarker changes in AD: previous work suggests that T217 is phosphorylated early in AD around the time of amyloid plaque deposition, whereas T205 is phosphorylated later and closer to neurofibrillary tangle accumulation and symptom onset26. Here, MAPT is linked to Alzheimer disease.